RNA, U6 small nuclear 386, pseudogene (RNU6-386P)

RNU6-386P is a processed pseudogene derived from the U6 small nuclear RNA gene family. Pseudogenes like RNU6-386P are DNA segments that resemble functional genes but have lost their capacity to encode fully functional proteins or RNAs due to mutations, deletions, or insertional events[1][3]. The U6 snRNA is normally involved in the spliceosome complex for pre-mRNA splicing, but the pseudogene version is not functionally transcribed into the same mature snRNA[2][3]. Some pseudogenes are known to be transcribed and can have regulatory roles in gene expression (such as acting as miRNA decoys or forming small interfering RNAs through RNA interference pathways), but direct evidence for biological activity or disease connection for RNU6-386P is lacking[1][4]. Processed pseudogenes typically arise from reverse transcription and integration of RNA sequences back into the genome, bearing characteristics like polyA tracts and direct repeats[1][3]. RNU6-386P may be transcribed, but does not contribute to spliceosomal activity nor serve as a drug target. It should be considered a noncoding genomic element, often used for evolutionary or functional studies regarding pseudogene roles in human biology[1][3][4]. If requesting a molecule for drug discovery or therapeutic targeting, RNU6-386P is not a valid entry: it is not a protein, receptor, enzyme, nor a functional RNA relevant for therapeutic intervention.

Other names

RNU6-386PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene

None. No mechanisms of action for drugs relating to RNU6-386P.